+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sodium Oxybate Oral Solution Market by Product Type (Brand Xyrem, Brand Xywav, Generic), Indication (Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Off Label Use), End User, Distribution Channel, Patient Age Group - Global Forecast 2025-2030- Product Image
Sodium Oxybate Oral Solution Market by Product Type (Brand Xyrem, Brand Xywav, Generic), Indication (Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Off Label Use), End User, Distribution Channel, Patient Age Group - Global Forecast 2025-2030- Product Image
Sale

Sodium Oxybate Oral Solution Market by Product Type (Brand Xyrem, Brand Xywav, Generic), Indication (Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Off Label Use), End User, Distribution Channel, Patient Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6125185
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The therapeutic landscape for sleep disorder management has experienced remarkable evolution, with sodium oxybate oral solution emerging as a cornerstone treatment for narcolepsy and related conditions. Originally introduced to address the debilitating symptoms of narcolepsy with cataplexy, its clinical efficacy, safety profile, and patient-centered delivery mechanism have driven sustained interest among clinicians, payers, and patients alike.

Amidst a backdrop of expanding research into sleep physiology and the growing prevalence of sleep disorders, stakeholders across the healthcare continuum have embraced this medication’s capacity to improve nighttime sleep consolidation, reduce daytime somnolence, and enhance overall quality of life. In parallel, the market has witnessed regulatory refinements, novel formulation approvals, and increasing awareness campaigns that together have shaped both prescriber behavior and patient adoption pathways.

This executive summary sets the stage for a deep dive into the transformative trends defining this sector, the multifaceted impacts of forthcoming tariff implementations in the United States, and the nuanced segmentation insights that illuminate key opportunities. By tracing the interplay of clinical innovation, policy shifts, and competitive dynamics, this introduction provides decision-makers with the essential context needed to navigate a market characterized by rapid change and strategic complexity.

Uncover the critical clinical innovations, digital health integrations, and regulatory realignments reshaping the sodium oxybate oral solution market landscape

In recent years, the sodium oxybate oral solution market has undergone transformative shifts that reconfigure traditional supply chains, clinical practices, and patient engagement models. Advances in formulation science have yielded more refined dosing regimens that minimize adverse effects while optimizing therapeutic outcomes. This progress coincides with tightening regulatory frameworks that enforce stringent risk management strategies, spurring manufacturers to invest heavily in patient education, adherence support programs, and digital health platforms.

Moreover, the integration of telemedicine into sleep disorder management has revolutionized access to specialist care, enabling remote titration and monitoring of sodium oxybate therapy. As specialty sleep centers expand their capabilities, collaborations with clinics and home care providers have strengthened the continuum of care, ensuring seamless transitions between inpatient and outpatient settings.

At the same time, payers are increasingly evaluating real-world evidence to inform formulary positioning, prompting all stakeholders to demonstrate value through health economic and outcomes research. These converging forces are reshaping prescribing behaviors and reinforcing the patient-centric ethos at the heart of sustainable market growth.

Explore how the forthcoming U.S. tariff measures set for 2025 will ripple through supply chains, production costs, and pricing strategies in the sodium oxybate oral solution sector

The implementation of new United States tariffs in 2025 exerts a cumulative effect on the sodium oxybate oral solution market by elevating the cost of key active pharmaceutical ingredients, excipients, and specialized packaging components sourced internationally. Manufacturers face pressure to recalibrate sourcing strategies, as higher import duties translate into increased production expenses. This dynamic necessitates agile supply chain adjustments, including the identification of alternative suppliers and greater reliance on domestic manufacturing capabilities.

Consequently, pricing strategies must be reexamined across the value chain, as distributors and specialty pharmacies seek to mitigate margin compression while maintaining patient affordability. In addition, raw material shortages prompted by tariff-induced supply disruptions could lead to temporary manufacturing slowdowns, heightening the importance of risk mitigation plans and inventory buffer policies.

Importantly, the redistribution of cost burdens may accelerate discussions around value-based contracting, in which payers and providers tie reimbursement to measurable patient outcomes. Such arrangements could prove instrumental in preserving access to sodium oxybate therapy amid evolving economic constraints.

Delve deep into multifaceted segmentation dynamics that uncover how product variants, indications, care settings, distribution pathways, and patient age groups shape market opportunities

Insight into market segmentation reveals the diverse factors shaping demand patterns and competitive positioning within the sodium oxybate oral solution landscape. Distinctions among brand Xyrem, brand Xywav, and generic irritant-free formulations influence stakeholder perceptions of medication efficacy, safety, and overall value proposition. Meanwhile, differences in clinical presentation between narcolepsy with cataplexy, narcolepsy without cataplexy, and various off-label applications drive tailored prescribing pathways and reimbursement considerations.

The perspective of end users-whether within outpatient clinics, home care settings, hospitals, or specialized sleep treatment centers-further informs distribution models and service offerings, as each setting requires distinct logistical and patient support structures. Likewise, channels ranging from hospital pharmacies to online and retail outlets dictate the reach and convenience of product access, shaping patient adherence and therapy initiation timelines.

Patient age also emerges as a critical lens through which treatment protocols are adapted, with adult populations subdivided into middle-aged and younger adults, and pediatric cohorts distinguished between adolescents and younger children. These age-based classifications underscore the need for flexible dosing strategies, educational materials customized to caregivers and patients, and rigorous safety monitoring across different life stages.

Analyze the distinct regional landscapes in the Americas, EMEA, and Asia-Pacific that drive varying access models, regulatory approaches, and payer expectations

Regional trends paint a vivid portrait of heterogeneous growth drivers and access challenges across the globe. In the Americas, robust reimbursement frameworks and established sleep disorder treatment protocols foster high product penetration, yet evolving payer scrutiny and cost containment measures require stakeholders to substantiate real-world value. Transitional approaches to pricing and contracting remain central as the region navigates escalating healthcare expenditures and seeks scalable patient support solutions.

Within Europe, the Middle East, and Africa, national health system structures create a patchwork of market entry pathways, from centralized tender processes in certain European territories to private insurance models in the Middle East. Stakeholders must navigate varying regulatory timelines and local manufacturing requirements, intensifying the importance of market access planning and strategic partnerships.

In the Asia-Pacific region, rapid urbanization and increasing awareness of sleep disorders drive momentum, although formularies are often influenced by cost-sensitive reimbursement authorities. Cross-border distribution dynamics and emerging specialty pharmacy networks play a pivotal role in overcoming geographic and infrastructural barriers to ensure consistent patient access.

Examine how originator firms, generic challengers, and strategic partnerships are competing through innovation, patient support, and evidence generation

Competitive dynamics in the sodium oxybate oral solution market center on a blend of established pharmaceutical leaders and emerging specialty players. Key originators have reinforced their market positions through continuous product innovation, expanding safety programs, and forging strategic alliances with specialty pharmacy networks to streamline distribution and patient support.

Simultaneously, generic entrants and compounding providers challenge pricing expectations, prompting originators to differentiate through enhanced risk mitigation services and proprietary adherence platforms. Partnerships between developers and contract manufacturing organizations have also intensified, allowing faster scale-up of new formulations and ensuring supply continuity.

Companies investing in real-world evidence generation and health economics studies are gaining a competitive edge, as payers and health systems demand proof of long-term benefits. The strategic alignment of sales, medical affairs, and market access teams has become a crucial factor in securing favorable formulary placement and fostering collaborative relationships with key opinion leaders across diverse care settings.

Implement integrated strategies spanning supply chain resilience, real-world evidence generation, patient-centric engagement, and value-based contracting to secure market leadership

To thrive amid evolving market dynamics, industry leaders should prioritize several strategic imperatives. First, strengthening supply chain resilience by diversifying sourcing options and establishing domestic manufacturing partnerships will mitigate risks associated with tariff-driven cost pressures. Next, leveraging advanced data analytics to generate real-world evidence can substantiate the clinical and economic value of sodium oxybate therapy, facilitating favorable contracting negotiations with payers.

Moreover, enhancing patient-centric initiatives-such as tailored educational resources for different age cohorts and digitally enabled adherence support-will bolster long-term therapy outcomes and reinforce stakeholder trust. Embracing flexible pricing models, including value-based agreements tied to patient outcomes, can address payer cost-containment objectives while preserving access.

Finally, cultivating multidisciplinary collaborations across clinics, home care services, hospitals, and specialty centers will optimize care pathways, ensuring that sodium oxybate treatment protocols are seamlessly integrated into broader sleep disorder management strategies.

Unveil the robust multi-methodological approach encompassing secondary analysis, expert interviews, and real-world data triangulation that underlies these market insights

This report’s findings draw upon a rigorous, multi-method research framework combining comprehensive secondary research, primary expert interviews, and qualitative validation. The secondary phase included systematic reviews of peer-reviewed journals, regulatory filings, public financial disclosures, and industry white papers to map the competitive and policy environment.

Building on these insights, in-depth interviews were conducted with leading neurologists, sleep specialists, pharmacists, and payer representatives to capture nuanced perspectives on clinical practice trends, formulary decisions, and patient support needs. These expert discussions were complemented by analyses of real-world data sources, including de-identified claims databases and treatment registries, to ground qualitative observations in empirical evidence.

Finally, all data inputs underwent iterative triangulation, ensuring consistency across sources and reinforcing the report’s credibility. This structured methodology underpins the strategic recommendations and market insights presented herein.

Synthesize the pivotal market drivers, economic factors, and competitive imperatives that define the current and future landscape of sodium oxybate oral solution

In summary, sodium oxybate oral solution occupies a central role in the evolving management of sleep disorders, driven by clinical innovation, regulatory adaptation, and shifting economic landscapes. The convergence of new formulation science, digital health integration, and outcome-driven reimbursement models underscores a market in flux yet ripe with opportunity.

Tariff-related cost challenges necessitate proactive supply chain strategies and novel contracting approaches, while nuanced segmentation and regional dynamics highlight the importance of tailored market access planning. Competitive differentiation will hinge on the ability to substantiate value through real-world evidence, deliver patient-centric services, and foster collaborative care networks across diverse settings.

Looking ahead, industry participants equipped with integrated strategic frameworks and a clear understanding of regional, clinical, and economic variables are best positioned to navigate this complex terrain and capitalize on the growing demand for comprehensive sleep disorder therapeutics.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Brand Xyrem
    • Brand Xywav
    • Generic
  • Indication
    • Narcolepsy With Cataplexy
    • Narcolepsy Without Cataplexy
    • Off Label Use
  • End User
    • Clinics
    • Home Care Settings
    • Hospitals
    • Specialty Sleep Centers
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Patient Age Group
    • Adult
      • Middle Age
      • Young Adults
    • Geriatric
    • Pediatric
      • Adolescents
      • Children
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Jazz Pharmaceuticals plc
  • Hikma Pharmaceuticals PLC

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing approval and launch of generic sodium oxybate formulations by multiple manufacturers boosting market competition
5.2. Expansion of patient assistance programs and copay support schemes to improve access and adherence rates for sodium oxybate therapy
5.3. Integration of telemedicine and home delivery services to streamline sodium oxybate prescription fulfilment and monitoring
5.4. Emerging clinical research into novel oxybate analogs and extended release formulations aimed at reducing dosing frequency
5.5. Strategic partnerships between specialty pharmacies and biotech companies to optimize supply chain for sodium oxybate
5.6. Shift in reimbursement policies and prior authorization requirements impacting sodium oxybate affordability and market uptake
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sodium Oxybate Oral Solution Market, by Product Type
8.1. Introduction
8.2. Brand Xyrem
8.3. Brand Xywav
8.4. Generic
9. Sodium Oxybate Oral Solution Market, by Indication
9.1. Introduction
9.2. Narcolepsy With Cataplexy
9.3. Narcolepsy Without Cataplexy
9.4. Off Label Use
10. Sodium Oxybate Oral Solution Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care Settings
10.4. Hospitals
10.5. Specialty Sleep Centers
11. Sodium Oxybate Oral Solution Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Sodium Oxybate Oral Solution Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.2.1. Middle Age
12.2.2. Young Adults
12.3. Geriatric
12.4. Pediatric
12.4.1. Adolescents
12.4.2. Children
13. Americas Sodium Oxybate Oral Solution Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Sodium Oxybate Oral Solution Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Sodium Oxybate Oral Solution Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Jazz Pharmaceuticals plc
16.3.2. Hikma Pharmaceuticals PLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SODIUM OXYBATE ORAL SOLUTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SODIUM OXYBATE ORAL SOLUTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SODIUM OXYBATE ORAL SOLUTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. SODIUM OXYBATE ORAL SOLUTION MARKET: RESEARCHAI
FIGURE 26. SODIUM OXYBATE ORAL SOLUTION MARKET: RESEARCHSTATISTICS
FIGURE 27. SODIUM OXYBATE ORAL SOLUTION MARKET: RESEARCHCONTACTS
FIGURE 28. SODIUM OXYBATE ORAL SOLUTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SODIUM OXYBATE ORAL SOLUTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY BRAND XYREM, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY BRAND XYREM, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY BRAND XYWAV, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY BRAND XYWAV, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY NARCOLEPSY WITH CATAPLEXY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY NARCOLEPSY WITH CATAPLEXY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY NARCOLEPSY WITHOUT CATAPLEXY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY NARCOLEPSY WITHOUT CATAPLEXY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY OFF LABEL USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY OFF LABEL USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY SPECIALTY SLEEP CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY SPECIALTY SLEEP CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY MIDDLE AGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY MIDDLE AGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY CHILDREN, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 95. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 104. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 105. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 106. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 107. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 108. CANADA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 109. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 112. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 113. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 118. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 119. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 120. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 121. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 122. MEXICO SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 181. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 190. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 191. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 192. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 193. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 194. GERMANY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 195. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 204. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 205. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 206. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 207. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 208. FRANCE SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 223. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 226. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 227. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 232. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 233. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 234. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 235. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 236. ITALY SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 237. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 240. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 241. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 246. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 247. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 248. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 249. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 250. SPAIN SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 293. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 302. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 303. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 304. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 305. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 306. DENMARK SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS SODIUM OXYBATE ORAL SOLUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (US

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Sodium Oxybate Oral Solution market report include:
  • Jazz Pharmaceuticals plc
  • Hikma Pharmaceuticals PLC

Related Reports

Sodium Oxybate Oral Medications Market by Indication (Idiopathic Hypersomnia, Narcolepsy, Off-Label Use), Strength (Four Point Five Gram, Nine Gram, Seven Point Five Gram), Distribution Channel, Dosage Form, End User, Packaging Type, Patient Age Group - Global Forecast 2025-2030 - Product Image

Sodium Oxybate Oral Medications Market by Indication (Idiopathic Hypersomnia, Narcolepsy, Off-Label Use), Strength (Four Point Five Gram, Nine Gram, Seven Point Five Gram), Distribution Channel, Dosage Form, End User, Packaging Type, Patient Age Group - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Drugs Market Report and Forecast 2024-2032 - Product Image

Narcolepsy Drugs Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2031F - Product Image

Narcolepsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2031F

  • Report
  • 188 Pages
  • Global
From
Narcolepsy Market Report 2025 - Product Image

Narcolepsy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.